Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel R Moskop
Observed names:
Daniel Moskop,
Daniel R. Moskop
Institution:
University of Colorado Anschutz
Observed institutions:
Tisch Cancer Institute,
University of Colorado Anschutz,
University of Colorado Denver,
Icahn School of Medicine at Mount Sinai
ORCID:
0000-0002-2772-8427
Observed ORCID:
0000-0002-2772-8427
OpenAlex ID:
A5107589522
Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleation
2021
·
Maria Feola
, Andrea Zamperone
, et al.
·
Communications Biology
·
8
PDF
Understanding MDS stem cells: Advances and limitations
2024
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
·
Seminars in Hematology
·
3
PDF
The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
·
Blood Cancer Discovery
·
2
PDF
Aberrant Responsiveness of Erythropoiesis to Iron Deficiency in Polycythemia Vera
2019
·
Maria Feola
, Daniel Moskop
, et al.
·
Blood
·
2
Table S6 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S1 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S11 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S3 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S13 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S9 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S10 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S4 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S2 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S14 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S4 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S8 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S2 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S1 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S3 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Data from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S7 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S5 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Table S12 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Figure S5 from The Nicotinamide Salvage Pathway Is a Metabolic Vulnerability of High-Risk MDS Stem Cells
2026
·
Sweta B. Patel
, Daniel R. Moskop
, et al.
Ferroptosis, foiled: the ENO1-SCD1 axis in AML
2026
·
Daniel R. Moskop
, Eric M. Pietras
·
Blood Advances
Show more works
View as search
Works count:
26
Citation count:
15
H-index:
2
I10-index:
Year
Topic
Type